An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) are the hepatic manifestations of the metabolic syndrome; worrisome is the booming increase in pediatric age. To recreate the full spectrum of juvenile liver pathology and investigate the gender impact, male and femal...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4938400?pdf=render |
_version_ | 1811294926948794368 |
---|---|
author | Veronica Marin Natalia Rosso Matteo Dal Ben Alan Raseni Manuela Boschelle Cristina Degrassi Ivana Nemeckova Petr Nachtigal Claudio Avellini Claudio Tiribelli Silvia Gazzin |
author_facet | Veronica Marin Natalia Rosso Matteo Dal Ben Alan Raseni Manuela Boschelle Cristina Degrassi Ivana Nemeckova Petr Nachtigal Claudio Avellini Claudio Tiribelli Silvia Gazzin |
author_sort | Veronica Marin |
collection | DOAJ |
description | Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) are the hepatic manifestations of the metabolic syndrome; worrisome is the booming increase in pediatric age. To recreate the full spectrum of juvenile liver pathology and investigate the gender impact, male and female C57Bl/6 mice were fed with high fat diet plus fructose in the drinking water (HFHC) immediately after weaning (equal to 3-years old human), and disease progression followed for 16 weeks, until adults (equal to 30-years old human). 100% of subjects of both genders on HFHC diet developed steatosis in 4weeks, and some degree of fibrosis in 8weeks, with the 86% of males and 15% of females presenting a stage 2 fibrosis at 16weeks. Despite a similar final liver damage both groups, a sex difference in the pathology progression was observed. Alterations in glucose homeostasis, dyslipidemia, hepatomegaly and obese phenotype were evident from the very beginning in males with an increased hepatic inflammatory activity. Conversely, such alterations were present in females only at the end of the HFHC diet (with the exception of insulin resistance and the hepatic inflammatory state). Interestingly, only females showed an altered hepatic redox state. This juvenile model appears a good platform to unravel the underlying gender dependent mechanisms in the progression from NAFLD to NASH, and to characterize novel therapeutic approaches. |
first_indexed | 2024-04-13T05:25:50Z |
format | Article |
id | doaj.art-8877189aed67467aafe2678a3dc7438d |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-04-13T05:25:50Z |
publishDate | 2016-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-8877189aed67467aafe2678a3dc7438d2022-12-22T03:00:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01117e015881710.1371/journal.pone.0158817An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.Veronica MarinNatalia RossoMatteo Dal BenAlan RaseniManuela BoschelleCristina DegrassiIvana NemeckovaPetr NachtigalClaudio AvelliniClaudio TiribelliSilvia GazzinNon Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) are the hepatic manifestations of the metabolic syndrome; worrisome is the booming increase in pediatric age. To recreate the full spectrum of juvenile liver pathology and investigate the gender impact, male and female C57Bl/6 mice were fed with high fat diet plus fructose in the drinking water (HFHC) immediately after weaning (equal to 3-years old human), and disease progression followed for 16 weeks, until adults (equal to 30-years old human). 100% of subjects of both genders on HFHC diet developed steatosis in 4weeks, and some degree of fibrosis in 8weeks, with the 86% of males and 15% of females presenting a stage 2 fibrosis at 16weeks. Despite a similar final liver damage both groups, a sex difference in the pathology progression was observed. Alterations in glucose homeostasis, dyslipidemia, hepatomegaly and obese phenotype were evident from the very beginning in males with an increased hepatic inflammatory activity. Conversely, such alterations were present in females only at the end of the HFHC diet (with the exception of insulin resistance and the hepatic inflammatory state). Interestingly, only females showed an altered hepatic redox state. This juvenile model appears a good platform to unravel the underlying gender dependent mechanisms in the progression from NAFLD to NASH, and to characterize novel therapeutic approaches.http://europepmc.org/articles/PMC4938400?pdf=render |
spellingShingle | Veronica Marin Natalia Rosso Matteo Dal Ben Alan Raseni Manuela Boschelle Cristina Degrassi Ivana Nemeckova Petr Nachtigal Claudio Avellini Claudio Tiribelli Silvia Gazzin An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. PLoS ONE |
title | An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. |
title_full | An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. |
title_fullStr | An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. |
title_full_unstemmed | An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. |
title_short | An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. |
title_sort | animal model for the juvenile non alcoholic fatty liver disease and non alcoholic steatohepatitis |
url | http://europepmc.org/articles/PMC4938400?pdf=render |
work_keys_str_mv | AT veronicamarin ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT nataliarosso ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT matteodalben ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT alanraseni ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT manuelaboschelle ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT cristinadegrassi ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT ivananemeckova ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT petrnachtigal ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT claudioavellini ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT claudiotiribelli ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT silviagazzin ananimalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT veronicamarin animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT nataliarosso animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT matteodalben animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT alanraseni animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT manuelaboschelle animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT cristinadegrassi animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT ivananemeckova animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT petrnachtigal animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT claudioavellini animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT claudiotiribelli animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis AT silviagazzin animalmodelforthejuvenilenonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis |